Navigation Links
MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference
Date:5/13/2011

GAITHERSBURG, Md., May 13, 2011 /PRNewswire/ -- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011.  "These data advance our understanding of thoracic diseases, highlighting our continued commitment to help improve patient health," said Bing Yao, Senior Vice President and Leader of the RIA innovative Medicines Unit (iMED) at MedImmune.

MedImmune abstracts to be presented at the ATS International Conference include:

  • IL-1 Family Members Have Different Effects on the Innate Pro-inflammatory and Anti-viral Responses of Epithelial Cells to Rhinovirus. Briend E, et al. Poster Session: May 16, 2011 Time: 10:45 - 12:30 PM,  Colorado Convention Center Area J, Hall B (Upper Level)
  • Cytokine Profiling in Severe Asthma Sub-phenotypes Using Factor and Cluster Analysis. Desai D, et al. Poster Session: May 16, 2011 Time: 3 - 3:15 PM, HRD Ballroom A-B-C (3rd Level)
  • Expression Patterns of Interleukin-1 Receptor 1 in COPD Patients, Smokers and Never-smoking Control Subjects. Bergqyist A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area E, Hall B (Upper Level)
  • Full Length IL-33 Activates Primary Human Mast Cells and It's Inhibited by Neutralising Antibodies. Cohen S, et al. Poster Session: May 17, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area F, Hall B (Upper Level)
  • The Epithelial-derived Signals TSLP, IL-25 and IL-33 Converge on OX40L to Elicit House-dust Mite 0 Induced Allergic Airway Inflammation in Mice. Llop-Guerva A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area K, Hall B (Upper Level)
  • In Vitro Cellular Response to Respiratory Syncytial Virus and Human Rhinovirus Infection of Primary Human Airway Epithelial Cells Derived From Healthy and COPD/Asthmatic Donors. Svabek C, et al. Poster Session: May 15, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area J, Hall B (Upper Level)
  • Comparison of the Preventative, Therapeutic and Prophylactic Effects of Anti-g and Anti-f RSV Glycoprotein Antibodies in the Response to Primary and Secondary RSV Infection. Han J, et al. Poster Session: May 18, 2011 Time: 2 – 4:30 PM, Colorado Convention Center Rooms 503-504 (Street Level)
  • Longitudinal Measures of Pulmonary Function in Healthy Late Preterm Infants Delivered at 33-36 Weeks of Gestation. McEvoy C, et al. Poster Session: May 16, 2011 Time: 2 – 4:30 PM, Colorado Convention Center Rooms 501-502 (Street Level)

Additional information about the 2011 ATS conference can be found at: http://conference.thoracic.org/

About MedImmune

MedImmune, the global biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN), has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. With an advancing pipeline of promising drug candidates, MedImmune strives to deliver life-changing products, rewarding careers to our employees and a tireless commitment to improving patient health. For more information, visit MedImmune's website at www.medimmune.com. 


'/>"/>
SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Related medicine technology :

1. Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™
2. MedImmune to Present 11 Abstracts on Influenza at 45th Annual National Immunization Conference
3. MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
4. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
5. MedImmune Focused on Revolutionizing Cancer Care
6. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
7. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
8. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
9. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
10. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
11. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):